Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1M | $3.9M | $3.9M | $3.1M | $352.1K | −$33.5K | $18.3M | $62.6M |
| Cost of revenue | $945.8K | $825.3K | $6.8M | $61.8K | $372.5K | $12.4M | $12.4M | $40.1M |
| Gross profit | $1.2M | $3.1M | −$2.8M | $3.1M | −$20.3K | −$12.4M | $6.0M | $22.5M |
| Gross margin | 55.0% | 79.1% | -71.9% | 98.0% | -5.8% | 36914.6% | 32.6% | 36.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$3.2M | −$8.7M | −$7.7M | −$760.6K | −$1.7M | −$1.0M | −$4.8M | −$5.5M |
| EBITDA | −$3.3M | $4.2M | −$7.4M | −$504.5K | −$1.6M | −$1.4M | −$3.2M | −$10.4M |
| Net income | −$3.1M | −$8.7M | −$8.1M | −$760.6K | −$2.3M | −$2.7M | −$4.4M | −$15.6M |
| Net margin | -147.0% | -219.6% | -204.6% | -24.2% | -664.9% | 7951.3% | -23.9% | -24.9% |
| EPS (diluted) | -0.13 | -0.29 | -0.24 | -0.02 | -0.07 | -0.06 | -0.10 | -0.16 |
Annual figures · source: Financial Modeling Prep
EVOME MEDICAL TECHNOLGIES
No one on the platform currently holds LNDZF.
No tracked institution reports a position in LNDZF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2020-12-15 | 0.737-for-1reverse |
| 2016-01-27 | 1-for-8.871reverse |
No one on the platform has traded LNDZF yet.
| — |
| $447175 |
| — |
| NHIQNantHealth, Inc. | $0.01 | +0.00% | $329656 | — |
| NXNNNexeon MedSystems Inc. | $0.00 | +0.00% | $78625 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.